1. Gudjonsson JE, Elder JT. Psoriasis: epidemiology. Clin Dermatol. 2007;25(6):535546....<\/p>\n
2. Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005;64(suppl 2):ii18ii23. <\/p>\n
3. Capon F, Trembath RC, Barker JN. An update on the genetics of psoriasis. Dermatol Clin. 2004;22(4):339347. <\/p>\n
4. Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826850. <\/p>\n
5. Kimball AB, Gladman D, Gelfand JM, et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol. 2008;58(6):10311042. <\/p>\n
6. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263271. <\/p>\n
7. Habif TP. Psoriasis and other papulosquamous diseases. In: Clinical Dermatology. 5th ed. Hanover, N.H.: Mosby Elsevier; 2010:264275. <\/p>\n
8. Reich K. Approach to managing patients with nail psoriasis. J Eur Acad Dermatol Venereol. 2009;23(suppl 1):1521. <\/p>\n
9. Gottlieb A, Korman NJ, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58(5):851864. <\/p>\n
10. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):26652673. <\/p>\n
11. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137(3):280284. <\/p>\n
12. Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol. 2004;51(5):704708. <\/p>\n
13. Horn EJ, Fox KM, Patel V, Kimball AB, Gordon KB, Lebwohl MG. Treatment satisfaction and health-related quality of life among individuals with psoriasis: National Psoriasis Foundation Survey Findings. Psoriasis Forum. 2008;14(2):2734. <\/p>\n
14. Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41(3 pt 1):401407. <\/p>\n
15. Hsu S, Papp KA, Lebwohl MG, et al.; National Psoriasis Foundation Medical Board. Consensus guidelines for the management of plaque psoriasis. Arch Dermatol. 2012;148(1):95102. <\/p>\n
16. Menter A, Korman NJ, Elmets CA, et al.; American Academy of Dermatology. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60(4):643659. <\/p>\n
17. Drugdex system. http:\/\/thomsonreuters.com\/products_services\/healthcare\/healthcare_products\/a-z\/drugdex_system\/<\/a>. Accessed May 8, 2012. <\/p>\n 18. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol. 2010;62(1):114135. <\/p>\n 19. Stelara (ustekinumab) [package insert]. Horsham, Pa.: Janssen Biotech; 2012. http:\/\/www.stelarainfo.com\/pdf\/PrescribingInformation.pdf<\/a>. Accessed May 8, 2012. <\/p>\n 20. Clinical pharmacology. http:\/\/www.clinicalpharmacology.com<\/a> [login required]. Accessed January 4, 2012. <\/p>\n 21. Del Rosso JQ, Kim GK. The rationale behind topical vitamin D analogs in the treatment of psoriasis: where does topical calcitrol fit in? J Clin Aesthetic Derm. August 2010. http:\/\/www.jcadonline.com\/the-rationale-behind-topical-vitamin-d-analogs-in-the-treatment-of-psoriasis-where-does-topical-calcitriol-fit-in\/<\/a>. Accessed May 8, 2012. <\/p>\n 22. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009;61(3):451485. <\/p>\n <\/p>\n Go here to see the original:
\nPsoriasis - American Family Physician<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"